Table 2.
A partial list of signaling pathways linked to oxidative stress in gastric cancer.
| Signaling pathways | Reference |
|---|---|
| Cell cycle regulators: Cyclin D and Cyclin E; p53, p21Waf1/Cip1 and p27Kip1 |
(111, 112) (113, 114) |
| COX-2/PGE2 and LOX/leukotrienes signaling | (115–118) |
| E-cadherin and Wnt/β-catenin signaling | (119, 120) |
| EGFR, HER2 and Ras/MAPK signaling | (121, 122) |
| FAK signaling | (123, 124) |
| Grb2/HER2 signaling | (125) |
| Hedgehog signaling | (126) |
| HIF-1α signaling pathway | (127, 128) |
| Hippo signaling Pathway | (129, 130) |
| JAK/STAT signaling | (131) |
| Matrix metalloproteinase and plasminogen activator system | (132, 133) |
| MUC1 mucin-mediated signaling pathways | (134) |
| NF-κB signaling | (135) |
| Notch signaling | (136) |
| PI3K/AKT/mTOR signaling | (137, 138) |
| PGD2/PTGDR2 signaling | (139) |
| STAT3 pathway | (140, 141) |
| TLR4 signaling | (142) |
| TGFβ, bone morphogenetic protein and activin signaling | (143, 144) |
| VEGFR‐3 signaling | (145) |
| WNT-β-catenin-TCF signaling pathway | (146) |